42,299 results on '"Aortic Valve Stenosis"'
Search Results
2. Routine Versus Selective Protamine Administration to Reduce Bleeding Complications After Transcatheter Aortic Valve Implantation (POPular ACE TAVI)
3. Periprocedural Continuation Versus Interruption of Oral Anticoagulant Drugs During Transcatheter Aortic Valve Implantation (POPular PAUSE TAVI)
4. Impact of Elastin Mediated Vascular Stiffness on End Organs
5. A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis
6. Early Surgery Versus Conventional Treatment in Very Severe Aortic Stenosis (RECOVERY)
7. Structured Shared Decision Making for Patients Undergoing SAVR or TAVR (TOGETHER)
8. Portico and Navitor India Clinical Trial
9. Colchicine for Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement (Co-STAR)
10. Evaluation of the Viability and Safety of Early Discharge Protocol After TAVI Implantation (FAST TRACK)
11. WATCH-TAVR, WATCHMAN for Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement
12. The ShortCut™ Continued Access Study Protocol (ShortCut CAS)
13. Valve Performance of the SAPIEN 3 Ultra RESILIA Valve: A Prospective Registry With Central Echocardiography Analysis.
14. Early Valve Replacement Guided by Biomarkers of LV Decompensation in Asymptomatic Patients With Severe AS (EVoLVeD)
15. Feasibility of Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic, Severe Aortic Stenosis
16. An Investigational Drug on Clinical Outcomes in Patients With Aortic Stenosis (Narrowing of the Major Blood Vessel of the Heart)(MK-0653A-043 AM4)(COMPLETED)
17. Fibrosis in Chronic and Delayed Myocardial Infarction (FCDMI)
18. ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves
19. Mechanism of Decompensation Evaluation - Aortic Stenosis (MODE-AS)
20. EARLY TAVR: Evaluation of TAVR Compared to Surveillance for Patients With Asymptomatic Severe Aortic Stenosis (EARLY TAVR)
21. Williams Syndrome (WS) and Supravalvar Aortic Stenosis (SVAS) DNA and Tissue Bank
22. The Leaflex™ Early Feasibility Study
23. PARTNER 3 Trial - Aortic Valve-in-Valve
24. Effectiveness of TAP (Transversus Abdominis Plane) Block for Abdominal Aortic Surgery
25. Colchicine and Inflammation in Aortic Stenosis (CHIANTI)
26. Effect of PCSK9 Inhibitors on Calcific Aortic Valve Stenosis
27. FORWARD PRO Study Interventional Post-market Study With the Evolut™ PRO System
28. Detection of Aortic Stenosis With Smartphone Auscultation Using Machine Learning (HEARTBEAT-Pilot)
29. Perioperative Hemodynamic and Microcirculatory Physiological Study During TAVI (TAVI)
30. Balloon-Expandable Versus Self-expanding Transcatheter Heart Valve for Treatment of Symptomatic Native Aortic Valve Stenosis (BEST) (BEST)
31. Prospective Project to Identify Biomarkers of Morbidity and Mortality in Cardiovascular Interventional Patients (CAREBANK)
32. Functional Assessment In TAVI: FAITAVI (FAITAVI)
33. Comparison of Left Atrial Appendage Occlusion vs Standard Medical Therapy in Patients in AF Undergoing TAVI (TAVI/LAAO)
34. Left Atrial Appendage CLOSURE for the Prevention of Thromboembolisms in Patients Undergoing Aortic Bioprosthesis Surgery (LAA-CLOSURE)
35. Sedation or General Anesthesia During TAVR (ANESTAVI)
36. Investigation of the ALLEGRA THV System With a New Delivery System in Patients With Aortic Stenosis or Failed Surgical Bioprosthesis (EMPIRE)
37. LANDMARK Trial: a Randomised Controlled Trial of Myval THV (LANDMARK)
38. Medtronic Evolut Transcatheter Aortic Valve Replacement in Low Risk Patients
39. Safety & Efficacy Study of the Medtronic CoreValve® System-Treatment of Symptomatic Severe Aortic Stenosis With Significant Comorbidities in Extreme Risk Subjects Who Need Aortic Valve Replacement
40. Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI). (SURTAVI)
41. Evolut™ EXPAND TAVR II Pivotal Trial
42. ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve Implantation (ENVISION)
43. FIH Study of the GEMINUS TAVI System in Patients With Severe Symptomatic Aortic Stenosis
44. PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR (PROGRESS)
45. The ReTAVI Prospective Observational Registry
46. Cerebrovascular EveNts in Patients Undergoing TranscathetER Aortic Valve Implantation With Balloon-expandable Valves Versus Self-expandable Valves. (CENTER)
47. Randomized Trial of TAVI vs. SAVR in Patients With Severe Aortic Valve Stenosis at Low to Intermediate Risk of Mortality (DEDICATE)
48. Personalized, CT-guided Antithrombotic Therapy Versus Lifelong Single Antiplatelet Therapy to Reduce Thromboembolic and Bleeding Events in Non-atrial Fibrillation Patients After Transcatheter Aortic Valve Implantation (POP ATLANTIS)
49. Exercise-based Cardiac Rehabilitation in Patients With Aortic Stenosis After Transcatheter Aortic Valve Implantation (TAVI)
50. Prospective Evaluation of the Quality of Life of Elderly Patients Undergoing Transfemoral Percutanous Aortic Valve Replacement (TAVI) for the Treatment of Severe Aortic Stenosis. (TAVI QdV)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.